Dermatology

LiVDerm Set To Launch Its Brand-New Online MOPD Foundations of Pediatric Dermatology Certificate Course

Retrieved on: 
Wednesday, June 7, 2023
Learning, Certificate of Completion of Training, Arm, PAS, Dermatophytosis, Scabies, Impetigo, Catalog, Wart, Skin, Psoriasis, Dermatology, Student, Pediatrics, MD, Patient, Practitioner, Molluscum contagiosum, Adolescence, Knowledge, Diagnosis, Pityriasis rosea, Completion, Infantile hemangioma, Tutoring, Nursing

This innovative course consists of six in-depth modules that look at the most common pediatric skin conditions clinicians come face-to-face with on a daily basis.

Key Points: 
  • This innovative course consists of six in-depth modules that look at the most common pediatric skin conditions clinicians come face-to-face with on a daily basis.
  • What makes this course even more appealing to busy health care professionals is the fact that it is fully online and self-paced.
  • Led by world-renowned medical, aesthetic, and pediatric dermatology experts, LiVDerm empowers providers to educate, collaborate, and engage.
  • With a multipronged approach to mastering the myriad of subspecialties within the field, LiVDerm provides innovative and integrated education across the dermatology spectrum.

ASDS Opens Registration for Its Highly Rated “Advanced Injection Techniques” Course

Retrieved on: 
Tuesday, June 6, 2023
University, Q&A, Louisiana State University, Clinical associates, Anatomy, ASDS, Skin, MBA, Tulane University, Laser, Medical director, Art, Patient safety, AMA, Faculty, FRCPC, Society, Safety, New York University Grossman School of Medicine, Veterinary medicine, Dentistry, Nursing, Dermatology, MD

The invited course faculty includes:

Key Points: 
  • The invited course faculty includes:
    Vince Bertucci, MD, FRCPC – Dr. Bertucci is the current ASDS President.
  • Deirdre Hooper, MD – Dr. Hooper is a board certified dermatologist and serves on the ASDS Board of Directors.
  • Joely Kaufman, MD – Dr. Kaufman is a board certified dermatologist at Skin Associates of South Florida and Skin Research Institute in Coral Gables.
  • Registration is $979 for ASDS residents and members and $1,279 for non-member dermatologists.

Sol-Gel and Searchlight Pharma Announce Licensing Agreements to Commercialize TWYNEO® and EPSOLAY® in Canada

Retrieved on: 
Tuesday, June 6, 2023
Tretinoin, Rosacea, Partnership, Philosophy, Dermatology, Acquisition, Patient, Physician, NESS, OBI Pharma, Inc., Sol–gel process, Benzoyl peroxide, Health, Acne, Fine chemical, Pharmaceutical industry, Medical device

TWYNEO and EPSOLAY are two innovative, large-market, dermatology products that were developed by Sol-Gel.

Key Points: 
  • TWYNEO and EPSOLAY are two innovative, large-market, dermatology products that were developed by Sol-Gel.
  • Both products recently launched in the U.S., and Searchlight is to commercialize them in Canada over a fifteen-year term that is renewable for subsequent five-year periods.
  • In addition, Sol-Gel will be entitled to royalty percentages of all Canadian net sales ranging from low-double-digits to high teens.
  • We look forward to collaborating with Searchlight to maximize the presence of our two unique drugs, TWYNEO and EPSOLAY, in Canada, a leading commercial territory.”

Massachusetts Innovation Network Announces its 2023 Eddies Finalists

Retrieved on: 
Wednesday, June 7, 2023
Software, Other Health, Pharmaceutical, Other Natural Resources, Optical, Apps, Applications, Technology, Medical Devices, Agriculture, Natural Resources, Artificial Intelligence, Other Technology, Health, 3D, University, Innovation, Deafblindness, David M. Eddy, Movement, Government, Dermatology, System, Patient, NE, WPI, Fertility, Collaborative innovation network, Arthropathy, Virus, Health equity, Strep, Injury, Medical device, Medical imaging, Birth control

Massachusetts Innovation Network has announced the finalists for its signature innovation competition, The Eddies.

Key Points: 
  • Massachusetts Innovation Network has announced the finalists for its signature innovation competition, The Eddies.
  • The Eddies (formerly known as NE Innovation Awards) is the oldest innovation competition in the area, turning 37 this year.
  • All Finalists will demonstrate their Innovation and deliver a in-person to Judges and members of the Innovation Ecosystem, at The Eddies Innovation Showcase on Wednesday, October 4th.
  • Recognition for all teams, celebration of the season and award announcements will be made at The Eddies Evening of Innovation on Wednesday, November 8th.

DermTech Announces Contract With Hawaii Blues Plan for the Foundational Assay of Its DermTech Melanoma Test (DMT)

Retrieved on: 
Wednesday, June 7, 2023
Health, Genetics, Other Health, Clinical Trials, General Health, Biotechnology, Medicare, DMT, Dermatology, NPV, Melanoma, Skin, Health insurance, Blues

DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced an agreement with a Blues plan in Hawaii.

Key Points: 
  • DermTech, Inc. (NASDAQ: DMTK) (“DermTech” or the “Company”), a leader in precision dermatology enabled by a non-invasive skin genomics platform, today announced an agreement with a Blues plan in Hawaii.
  • The contract, which is in addition to a favorable coverage policy, enhances access to the foundational assay of the DermTech Melanoma Test (DMT) for the nearly 800,000 members of this plan.
  • The DMT is an innovative, non-invasive way to enhance melanoma detection with a greater than 99 percent negative predictive value (NPV).
  • “The DMT test results are clinically meaningful and actionable, improve patient care and reduce healthcare costs.

Are Salons and Barbershops the Missing Piece to Facilitate Better Skin and Scalp Health?

Retrieved on: 
Wednesday, June 7, 2023
Other Health, Men, General Health, Philanthropy, Lifestyle, Training, Consumer, Other Education, Education, Foundation, Women, Health, Dandruff, Medical Affairs Bureau, Dermatitis, Physician, Dermatology, Health equity, Quality of life, Atopic dermatitis, Bristol Myers Squibb, Social media, Doctor of Philosophy, Scalp, HEROES, Hair, Stigma, MD, Patient, Conditional sentence, Diagnosis, Knowledge, BIPOC, Skin, Health education, Nursing, Psoriasis

Created by, with, and for stylists, salons, and barbershops, with input from patients and health care professionals, GHLF’s HEROES program is a free platform to equip salon professionals to better support their clients with skin and scalp conditions.

Key Points: 
  • Created by, with, and for stylists, salons, and barbershops, with input from patients and health care professionals, GHLF’s HEROES program is a free platform to equip salon professionals to better support their clients with skin and scalp conditions.
  • As places of conversation, connection, and community, salons and barbershops play a key role in the health and well-being of their clients.
  • The survey showed that the top conversation topics among beauty professionals and their clients were their personal life (52%), skin health (46%), and hair health (43%).
  • Through the HEROES program, salons and barbershops can learn to provide welcoming environments for patients with chronic skin conditions, where they can feel accepted and understood without being judged.

BoomerangFX Partners with DrFirst to Launch E-Prescribing for Aesthetic Medicine Practices Across North America

Retrieved on: 
Thursday, June 8, 2023
Software as a service, Partnership, Electronic prescribing, EMR, Ground substance, Woman, Prescription, Pharmacy, Sale, Dermatology, EPCS, Acquisition, Patient, Charting, Physician, Investment, Practice management, CRM, Artificial intelligence, United Kingdom, Growth, Stripe, Research, Health, Nursing, Pharmaceutical industry, Medical device

Research suggests that aesthetic medicine is experiencing an explosion in consumer adoption and is proving to be increasingly recession resilient.

Key Points: 
  • Research suggests that aesthetic medicine is experiencing an explosion in consumer adoption and is proving to be increasingly recession resilient.
  • Cosmetic surgeons and physicians from a variety of disciplines are benefiting from the increased demand for facial and body enhancement procedures utilizing minimally invasive procedures.
  • "We are thrilled to incorporate DrFirst's medication management solutions into our industry-leading practice management platform," said Jerome Dwight, CEO and co-founder of BoomerangFX.
  • "We are pleased to partner with BoomerangFX," said G. Cameron Deemer, CEO of DrFirst.

PMB and Sutter Health announce groundbreaking for 100,000 square-foot medical office building in Roseville, Calif.

Retrieved on: 
Wednesday, June 7, 2023
Partnership, First Horizon Bank, Education, Sutter, MOHS, Graduate medical education, Partner (business rank), Blackford, Sutter Health, PMB, Physician, NHS Property Services, Dreyfuss, Facility, Nursing, Dermatology, Rheumatology, Endocrinology

ROSEVILLE, Calif., June 7, 2023 /PRNewswire/ -- PMB, a leading healthcare real estate developer, in partnership with Sutter Health, has broken ground on a 4-story, 100,000 square-foot medical office building in Roseville, CA.

Key Points: 
  • ROSEVILLE, Calif., June 7, 2023 /PRNewswire/ -- PMB, a leading healthcare real estate developer, in partnership with Sutter Health, has broken ground on a 4-story, 100,000 square-foot medical office building in Roseville, CA.
  • PMB and Sutter Health announce groundbreaking for 100,000 square-foot medical office building in Roseville, CA
    The building is located at 7 Medical Plaza Drive on the Sutter Roseville Medical Center campus and will be home to the Graduate Medical Education Program which will provide training and education for future physicians to support Sutter Health's system.
  • The remainder of the building will be occupied by Sutter Valley Medical Foundation and will provide: Cardiovascular, Bariatric, Dermatology, MOHS, Rheumatology, and Endocrinology services.
  • "At Sutter Health we're always advancing and finding ways to better serve our communities," Robert Mitsch, Vice President - Facility & Property Services at Sutter Health, said.

Skineez' Newly Announced T.E.D. HOSE, the Only FDA Cleared Hydrating Anti-Embolism Stockings and Socks for Pre-Operative and Post Operative Patients, Is Now Available at Walmart

Retrieved on: 
Tuesday, June 6, 2023
Bruise, Elasticity, Pressure, Skin care, Arthritis, Walmart, Edema, DVT, Ageing, Leg, Cardiology, Trial of the century, Pain, Biotechnology, Dermatology, Friction, Dry, Patient, Chemical oxygen demand, Deep vein thrombosis, Joint, FSA, Elective surgery, FDA, HSA, Skin, Cosmetics

Anti-Embolism Stockings and Socks will be available immediately at Walmart stores and on Walmart.com.

Key Points: 
  • Anti-Embolism Stockings and Socks will be available immediately at Walmart stores and on Walmart.com.
  • Anti-embolism stockings are used right after surgery to prevent DVT and blood clotting.
  • She invented the hydrating-wearable skincare technology after she had surgery and was given a drying stocking which led to problems.
  • Shear forces, friction, and pressure cause delicate skin to come apart with brief, light pressure, especially while applying compression.

DeepX Diagnostics Inc.'s DermoSight Receives FDA Clearance for Teledermatology Screening of Suspect Skin Cancer Lesions

Retrieved on: 
Tuesday, June 6, 2023
Mayo, Telehealth, US Food Sovereignty Alliance, Mayo Clinic, Diagnosis, Pharmacy, Food, Skin cancer, OTD, FDA, Teledermatology, Skin, Biopsy, Medical device, Medical imaging, Dermatology

WASHINGTON, June 6, 2023 /PRNewswire/ -- DeepX Diagnostics Inc., the skin cancer teledermatology and diagnostics company, announced today that its digital dermatoscope DermoSightTM received clearance from the US Food and Drug Administration (FDA) for teledermatology screening of suspect skin cancer lesions in the United States. The company is now ready to enter the US market on the back of over 180 thousand assessments in pharmacies and primary care clinics in Europe.

Key Points: 
  • DeepX Diagnostics Inc. to enter US market, having already performed over 180,000 skin lesions assessments in pharmacy and primary care to date in Europe.
  • WASHINGTON, June 6, 2023 /PRNewswire/ -- DeepX Diagnostics Inc., the skin cancer teledermatology and diagnostics company, announced today that its digital dermatoscope DermoSightTM received clearance from the US Food and Drug Administration (FDA) for teledermatology screening of suspect skin cancer lesions in the United States.
  • DermoSight is currently cleared to acquire skin lesion images for teledermatology assessment, like existing digital dermatoscopes.
  • It will help people with skin lesions of concern receive early diagnosis and effective treatment of skin cancer," said Christian Horn, the CEO at DeepX Diagnostics.